HealthEquity, Inc. (NASDAQ:HQY) Position Cut by Stifel Financial Corp

Stifel Financial Corp trimmed its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 10.1% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 19,268 shares of the company’s stock after selling 2,171 shares during the quarter. Stifel Financial Corp’s holdings in HealthEquity were worth $1,577,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. International Assets Investment Management LLC acquired a new stake in shares of HealthEquity in the 2nd quarter worth approximately $35,000. Paladin Wealth LLC acquired a new stake in HealthEquity in the third quarter worth approximately $39,000. Point72 Asia Singapore Pte. Ltd. bought a new position in HealthEquity during the 2nd quarter valued at $73,000. GAMMA Investing LLC increased its position in shares of HealthEquity by 57.8% during the 3rd quarter. GAMMA Investing LLC now owns 939 shares of the company’s stock valued at $77,000 after purchasing an additional 344 shares during the period. Finally, Quarry LP raised its stake in shares of HealthEquity by 418.8% in the 3rd quarter. Quarry LP now owns 1,349 shares of the company’s stock worth $110,000 after buying an additional 1,089 shares in the last quarter. 99.55% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at HealthEquity

In other HealthEquity news, Director Robert W. Selander sold 8,250 shares of HealthEquity stock in a transaction dated Wednesday, October 9th. The stock was sold at an average price of $82.98, for a total transaction of $684,585.00. Following the completion of the transaction, the director now owns 54,719 shares in the company, valued at approximately $4,540,582.62. The trade was a 13.10 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Stuart B. Parker sold 25,000 shares of the company’s stock in a transaction on Thursday, December 12th. The stock was sold at an average price of $96.72, for a total transaction of $2,418,000.00. Following the completion of the sale, the director now owns 19,061 shares of the company’s stock, valued at approximately $1,843,579.92. The trade was a 56.74 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 43,786 shares of company stock worth $4,140,387 over the last three months. Company insiders own 2.20% of the company’s stock.

HealthEquity Stock Up 0.2 %

HQY stock opened at $94.95 on Friday. HealthEquity, Inc. has a 12 month low of $63.87 and a 12 month high of $105.82. The company has a current ratio of 3.20, a quick ratio of 4.10 and a debt-to-equity ratio of 0.51. The stock has a market capitalization of $8.23 billion, a P/E ratio of 87.11, a price-to-earnings-growth ratio of 1.10 and a beta of 0.55. The firm has a 50-day moving average price of $94.80 and a 200-day moving average price of $84.55.

Analyst Ratings Changes

A number of research analysts recently issued reports on HQY shares. JMP Securities lifted their target price on HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a report on Tuesday, December 10th. The Goldman Sachs Group began coverage on shares of HealthEquity in a research report on Friday, November 15th. They issued a “neutral” rating and a $108.00 target price on the stock. BTIG Research upped their price objective on shares of HealthEquity from $110.00 to $130.00 and gave the company a “buy” rating in a research note on Thursday, November 14th. Royal Bank of Canada raised their price objective on shares of HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a research report on Tuesday, December 10th. Finally, Mizuho initiated coverage on HealthEquity in a research report on Wednesday, December 4th. They set an “outperform” rating and a $126.00 target price for the company. One analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $110.71.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.